However, after adjusting tumor size, lymph node metastasis, and TNM staging, multiple Cox regression revealed that RUFY3 expression could be considered an independent factor for predicting survival in lung adenocarcinoma patients. This evidence concerns the gene RUFY3 and neoplasm.